Português The use of cannabidiol as a treatment for autism

• Autor(a) principal: Abreu, Rafaella Raíssa Santos de
• Data de Publicação: 2023
• Outros Autores: Passos, Marco Aurélio Ninômia
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista JRG de Estudos Acadêmicos
• Texto Completo: http://revistajrg.com/index.php/jrg/article/view/525
• topic: Canabidiol; Transtorno do Espectro Autista; TEA; CBD; Tratamento; Cannabidiol; Autistic Spectrum Disorder; TEA; CBD; Treatment

This study aimed to analyze the benefit of using cannabidiol as a treatment in people with autism spectrum disorder, analyzing its effect on comorbidities and symptoms present on the spectrum. This is an integrative review with descriptive analysis on autism, its comorbidities, the use of cannabis components and CBD as a form of treatment for ASD. As a theoretical reference for the review, 19 studies from the main scientific article platforms were used. Through the study, the main comorbidities that affect autistic people were evidenced, being psychiatric, clinical signs and developmental delay such as intellectual impairment, anxiety, depression, attention deficit disorder with hyperactivity, obsessive-compulsive disorder, sleep disturbance, constipation and reflux , food selectivity, seizures and epilepsy. In pharmacological intervention, several drugs are used for each comorbidity, increasing the amount of drugs prescribed for ASD patients. Tests carried out with CBD showed its wide use as an anxiolytic and antipsychotic, in addition to resulting in behavioral and social improvements, covering several symptoms of autism and having mild side effects. It is concluded that cannabidiol proves to be a promising drug to treat the comorbidities and symptoms present in autism, however more specific studies are still needed to ensure CBD in relation to its prolonged use in autistic.